Spectra Optia® Apheresis System: current insights into clinical risks and benefits
International Journal of Clinical Transfusion Medicine · 2018-12 · Volume 6 · 33-40
DOI: 10.2147/ijctm.s104333 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Clinical Transfusion Medicine, 2018-12. Verfasst von Anne Klink und 1 weiteren Autor:innen. Die Arbeit wurde bisher 9-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Klink, A., & Rummler, S. (2018). Spectra Optia® Apheresis System: current insights into clinical risks and benefits. International Journal of Clinical Transfusion Medicine, Volume 6, 33-40. https://doi.org/10.2147/ijctm.s104333
Vancouver
Klink A, Rummler S. Spectra Optia® Apheresis System: current insights into clinical risks and benefits. International Journal of Clinical Transfusion Medicine. 2018;Volume 6:33-40. doi:10.2147/ijctm.s104333
BibTeX
@article{Klink2018,
author = {Klink, Anne and Rummler, Silke},
title = {Spectra Optia® Apheresis System: current insights into clinical risks and benefits},
journal = {International Journal of Clinical Transfusion Medicine},
year = {2018},
volume = {Volume 6},
pages = {33--40},
doi = {10.2147/ijctm.s104333}
}
EUVIMED